Merck Canada Provides $1.8M for Quebec Personalized Medicine Research Effort | GenomeWeb

NEW YORK (GenomeWeb News) – Merck Canada on Thursday announced a C$2 million (US$1.8 million) grant to a Quebec entity in support of research into personalized medicine approaches for cancer.

The grant is being provided to the Quebec-Consortium de recherché en oncologie Clinique (Q-CROC), which plans to use it for biomarker-driven clinical research into cancer. In particular, Merck noted a public-private partnership put forward by Q-CROC and the new Centre of Excellence PreThera Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.